Antibody Evolution to SARS-CoV-2 after Single-Dose Ad26.COV2.S Vaccine in Humans

Investigators examined the memory B cell response to single-dose Ad.26.COV.2 vaccination. Compared with mRNA vaccines, Ad.26.COV.2 recipients had significantly lower numbers of RBD-specific memory B cells one and a half or six months after vaccination.